Commercial Aquaculture Vaccines Market Size, Share & Trends Analysis Report By Pathogen Types (Bacteria and Viruses), Fish Species (Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur), End-Users, Region, And Segment Forecasts, 2023-2031

Report Id: 1027 Pages: 190 Last Updated: 27 May 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Commercial Aquaculture Vaccines Market Size is valued at 470.8 Million in 2024 and is predicted to reach 968.1 Million by the year 2034 at a 7.3 % CAGR during the forecast period for 2025-2034.

Commercial Aquaculture Vaccines Market info

Key Industry Insights & Findings from the Report:

  • The increasing consumption of seafood and the rising need for efficient disease management in intensive aquaculture systems boost the demand for vaccines
  • Innovations in vaccine technology, including species-specific formulations and advanced delivery methods, are enhancing the effectiveness of disease prevention in aquaculture.
  • Europe region dominated the overall market and accounted for a global revenue share in 2023.
  • Economic factors, such as fluctuations in fish prices and the financial instability of fish farming operations, can affect the ability of farmers to invest in vaccines.

Aquaculture is known as the farming of aquatic animals such as fish, tilapia, shrimp, molluscs, and Sea Bass in water. Aquaculture is the better source of income for the food industry. Vaccination plays an important role in commercial Aquaculture. Vaccination would be the best option to reduce bacterial and viral infections in aquaculture. The demand of the aquaculture vaccines market has been rising due to the advancements in the field of fish farming. Modern and advanced technologies, development, and launch of new aquaculture vaccines for different species enhance the growth of the aquaculture vaccines market.

The rising prevalence of bacterial infections among aquatic species is expected to boost demand for the commercial aquaculture vaccines market over the forecast period. Additionally, increasing global consumption and production of aquatic species has heightened the aquaculture vaccines market opportunities. However, the COVID-19 pandemic has created a negative impact on the aquaculture vaccines market. Also, rising awareness of animal-to-human pathogen transmission risks is expected to pull down the market for a short period of time. Moreover, stringent regulatory policies for approval of aquaculture vaccines, complex manufacturing procedures of vaccines, and the high cost of vaccines will limit the growth of the aquaculture vaccines market.

Competitive Landscape

Some of The Key Players in The Commercial Aquaculture Vaccines Market:

  • IDT Biologika GmbH (Ridgeway Biologicals Ltd)
  • MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
  • Ceva Biovac
  • Zoetis (PHARMAQAS)
  • Vaxxinova
  • Barramundi Asia Pte Ltd. (UVAXX Asia)
  • HIPRA
  • AniCon Labor GmbH
  • sanphar (ipeve)
  • Kennebec River Biosciences
  • Merck & Co. Inc.
  • Tecnovax
  • HIPRA
  • Virbac
  • Veterquimica S.A.
  • FeedVAX
  • KoVax (Phibro Animal Health)
  • Nisseiken Co., Ltd.
  • Other Prominent Players

Market Segmentation

The commercial aquaculture vaccines market is segmented into Pathogen Types, Fish Species, End-users and Regions. The Pathogen Types segment is further bifurcated into Bacteria and Viruses. In terms of Fish Species, the market can be divided into Salmon, Tilapia, Bream, Labris Bergylta, Cyprinus Carpio, Sea Bass, Trout, and Cyclopterus Lumpur. By End-users, the market is segmented into Fish Farming companies and Aquatic research institute. Based on the region, the commercial aquaculture vaccines market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Main regions of this market are North America, Europe, and Asia-Pacific. Asia-Pacific market is expected to grow faster in the future due to the growing aquaculture industry and development in vaccination. China is the leading country of this region.

Bacteria segment will drive the growth of the aquaculture vaccines market during the forecast period due to the rising prevalence of bacterial infections among aquatic species. Based on the fish species segment, salmon is a widely dominating species in the market, due to growing demand and rising production of salmon in leading developed countries and this will boost the aquaculture vaccines market in the future. Among the different end-users, fish farming companies will create more opportunities in this market.

Recent Developments:

  • In February 05, 2024 Merck Animal Health, Merck & Co., Inc., Rahway, N.J., USA (MSD Animal Health outside the U.S. and Canada), announced that it will purchase Elanco Animal Health Incorporated aqua business for $1.3 billion in cash. An unique portfolio of aquatic species medications, vaccines, nutritionals, and supplements, two aqua manufacturing sites in Canada and Vietnam, and a Chilean research center were acquired. The transaction is expected to close by mid-2024, pending regulatory approvals and other closing procedures.

The Commercial Aquaculture Vaccines Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 470.8 Million
Revenue Forecast In 2034 USD 968.1 Million
Growth Rate CAGR CAGR of 7.6% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Billion and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Pathogen Types, By Fish Species, By End-Users
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia
Competitive Landscape IDT Biologika GmbH (Ridgeway Biologicals Ltd), MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.), Ceva Biovac, Zoetis (PHARMAQAS), Vaxxinova, Barramundi Asia Pte Ltd. (UVAXX Asia), HIPRA, AniCon Labor GmbH, Sanphar (ipeve), Kennebec River Biosciences, and Others
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Global Commercial Aquaculture Vaccines Market Segmentation

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Pathogen Types

  • Bacteria
  • Virus

Commercial Aquaculture Vaccines Market

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Fish Species

  • Salmon
  • Tilapia
  • Bream
  • Labris Bergylta
  • Cyprinus Carpio
  • Sea Bass
  • Trout
  • Cyclopterus Lumpus

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on End-Users

  • Fish Farming companies
  • Aquatic research institute

Global Commercial Aquaculture Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Commercial Aquaculture Vaccines Market revenue (US$ Million) by Country, 2019 to 2030

  • U.S.
  • Canada

Europe Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Commercial Aquaculture Vaccines Market Revenue (US$ Million) by Country, 2019 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
4568
Security Code field cannot be blank!

Frequently Asked Questions

Commercial Aquaculture Vaccines Market Size is valued at 470.8 Million in 2024 and is predicted to reach 968.1 Million by the year 2034

The Commercial Aquaculture Vaccines Market is expected to grow at a 7.6% CAGR during the forecast period for 2025-2034.

IDT Biologika GmbH (Ridgeway Biologicals Ltd), MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.), Ceva Biovac, Zoetis (PHARMAQAS), Vaxxinova, Barramundi Asia

Commercial aquaculture vaccines market is segmented into Pathogen Types, Fish Species, End-users and Regions.

North America region is leading the Commercial aquaculture vaccines market.
Get Sample Report Enquiry Before Buying